Moderna enrols first patient in Phase I/II trial of mRNA-3704
Moderna’s mRNA-3704 will be administered via intravenous infusion in patients with isolated MMA. Credit: Arek Socha from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more